Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiprofen for Knee Osteoarthritis (TOPICAL)
NCT03199417Phase 3Terminated
- Sponsor
- University of Michigan
- Start
- May 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Multiprofen with Placebo (2 arms). Primary endpoint: Visual Analog Scale at 12 weeks. Started May 2017; status: terminated.
02
Drugs
ibuprofen + acetaminophen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03199417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03199417.